The Economist @TheEconomist
A new study was motivated by concerns that the vaccine’s efficacy was almost identical in each of the five age groups examined. The developer of Sputnik V disputes the findings https://t.co/iq4CFQ5gmE — PolitiTweet.org
Created
Sat Jun 25 10:45:28 +0000 2022
Likes
33
Retweets
8
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
The Economist @TheEconomist
A new study was motivated by concerns that the vaccine’s efficacy was almost identical in each of the five age groups examined. The developer of Sputnik V disputes the findings https://t.co/iq4CFQ5gmE — PolitiTweet.org